| 1573 |
1430: Inhibition of neurotransmitter release |
1432: Anti-depressant Activity |
Jun 23, 2017 |
Jun 23, 2017 |
1 AOP
|
| 3536 |
2311: PI3K-Akt pathway |
1115: Increase, ROS |
May 22, 2025 |
May 22, 2025 |
1 AOP
|
| 2403 |
1885: Inhibition of Plxna2 |
1886: Overexpression of rasl11b |
May 28, 2021 |
Dec 12, 2021 |
1 AOP
|
| 2851 |
2100: Inhibition of rapid delayed rectifying potassium current |
1961: Prolongation of Action Potential |
Jan 29, 2023 |
Jan 29, 2023 |
1 AOP
|
| 2974 |
2155: SULT1E1 inhibition |
1973: Increased, estrogens |
Jul 28, 2023 |
Jul 28, 2023 |
None
|
| 3390 |
2155: SULT1E1 inhibition |
2251: Increased E2 availability |
Nov 15, 2024 |
Feb 21, 2025 |
1 AOP
|
| 1891 |
1627: tyrosinase |
1628: Reduction of L-Dopaquinone |
May 3, 2019 |
May 3, 2019 |
1 AOP
|
| 3016 |
2174: Inhibition VEGF/VEGFR pathway |
2161: Increase, Vascular disrupting effects |
Aug 21, 2023 |
Aug 21, 2023 |
None
|
| 3025 |
2174: Inhibition VEGF/VEGFR pathway |
1928: increased,Vascular endothelial dysfunction |
Aug 21, 2023 |
Aug 21, 2023 |
1 AOP
|
| 775 |
766: Inhibition, 4-hydroxyphenyl-pyruvate dioxygenase (HPPD) enzyme |
775: Increased, Plasma tyrosine |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 635 |
619: Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT) |
620: Increased, serotonin (5-HT) 1 |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 643 |
619: Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT) |
626: Increased, serotonin (5-HT) |
Nov 29, 2016 |
Dec 3, 2016 |
5 AOPs
|
| 1208 |
619: Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT) |
1162: Increased, cilia movement |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1316 |
619: Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT) |
625: Increased, muscular waves in foot |
Jan 13, 2017 |
Jan 13, 2017 |
1 AOP
|
| 1317 |
619: Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT) |
1142: Increased, valve movement |
Jan 13, 2017 |
Jan 13, 2017 |
3 AOPs
|
| 1318 |
619: Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT) |
621: Increase, cilia movement |
Jan 13, 2017 |
Jan 13, 2017 |
3 AOPs
|
| 1319 |
619: Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT) |
1256: increased mantel display |
Jan 13, 2017 |
Jan 13, 2017 |
2 AOPs
|
| 1337 |
619: Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT) |
1161: Increased, oocyte maturation |
Jan 30, 2017 |
Jan 30, 2017 |
1 AOP
|
| 3474 |
619: Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT) |
1320: Increased, extracellular serotonin |
Jan 14, 2025 |
Feb 13, 2025 |
1 AOP
|
| 1880 |
1617: Inhibition, 5α-reductase |
1613: Decrease, DHT level |
Apr 18, 2019 |
Mar 20, 2026 |
4 AOPs
|
| 3452 |
1617: Inhibition, 5α-reductase |
1690: Decrease, circulating testosterone levels |
Dec 23, 2024 |
Dec 23, 2024 |
1 AOP
|
| 45 |
36: Inhibition, Aromatase |
3: Reduction, 17beta-estradiol synthesis by ovarian granulosa cells |
Nov 29, 2016 |
Nov 30, 2016 |
1 AOP
|
| 1767 |
36: Inhibition, Aromatase |
21: Altered regulation, Alpha hemoglobin |
Sep 13, 2018 |
Sep 13, 2018 |
None
|
| 2144 |
36: Inhibition, Aromatase |
1789: Reduction, E2 Synthesis by the undifferentiated gonad |
Jun 15, 2020 |
Jul 11, 2022 |
1 AOP
|
| 2167 |
36: Inhibition, Aromatase |
1790: Increased, Differentiation to Testis |
Jul 28, 2020 |
Dec 28, 2022 |
1 AOP
|